Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
US Army
Fish and Richardson
Cantor Fitzgerald
Deloitte
Farmers Insurance
Merck
Covington

Generated: April 26, 2018

DrugPatentWatch Database Preview

Alembic Pharms Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALEMBIC PHARMS LTD, and what generic and branded alternatives to ALEMBIC PHARMS LTD drugs are available?

ALEMBIC PHARMS LTD has fifty-three approved drugs.

There are five tentative approvals on ALEMBIC PHARMS LTD drugs.

Summary for Alembic Pharms Ltd
US Patents:0
Tradenames:47
Ingredients:47
NDAs:53

Drugs and US Patents for Alembic Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207073-001 Jul 17, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 091689-004 Jun 12, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd METRONIDAZOLE metronidazole CAPSULE;ORAL 079065-001 Jun 23, 2009 AB RX No No ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 200891-001 Oct 13, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Covington
AstraZeneca
Express Scripts
Dow
Citi
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.